Cilostazol inhibits leukocyte-endothelial cell interactions in murine microvessels after transient bilateral common

Takuya Fukuoka1, Takeshi Hayashi1, Makiko Hirayama1

  • 1Department of Neurology, Saitama Medical University International Medical Center, 1397-1 Yamane, Hidaka, Saitama 350-1298, Japan.

Brain Research
|December 7, 2013
PubMed

Insights

Cilostazol effectively reduced leukocyte rolling and adhesion in mouse brain vessels after stroke. This finding highlights cilostazol

Area of Science:

  • Neuroscience
  • Cerebrovascular Research
  • Inflammation Biology

Background:

  • Leukocyte behavior in cerebral microvasculature post-occlusion remains unclear.
  • Understanding leukocyte-endothelial interactions is crucial for stroke research.

Purpose of the Study:

  • To investigate the impact of cilostazol on leukocyte rolling and adhesion.
  • To examine these effects in murine cerebral microvessels following transient ischemia and reperfusion.

Main Methods:

  • Intravital fluorescence microscopy was used in four mouse groups: sham, ischemia/reperfusion (I/R), I/R + 3 mg/kg cilostazol, and I/R + 30 mg/kg cilostazol.
  • Leukocytes were labeled with acridine orange and observed at 3 and 6 hours post-reperfusion.
  • Quantification of rolling and adherent leukocytes per square millimeter per 30 seconds.

Main Results:

  • The I/R group showed significantly higher numbers of rolling and adherent leukocytes compared to sham and I/R+CZ30 mg/kg groups in both pial veins and arteries (P<0.05).
  • Cilostazol at 30 mg/kg significantly inhibited leukocyte-endothelial interactions.
  • Lower dose (3 mg/kg) did not show significant inhibition.

Conclusions:

  • Cilostazol, particularly at 30 mg/kg, demonstrates a protective effect by inhibiting leukocyte-endothelial interactions.
  • These findings suggest cilostazol's potential therapeutic value in mitigating inflammatory responses following cerebral ischemia and reperfusion.